Electrophile-First Screening Identifies Covalent Aminothiazole Scaffold Inhibitors for Ubiquitin-Conjugating Enzyme UBE2D2
Journal of Medicinal Chemistry · 12.11.2026 · 69 (21) · 25914-25929
DOI: 10.1021/acs.jmedchem.6c01896 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 20.10.2026. Verfasst von Siying Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Pesticide and Chemical Biology of Ministry of Education, Hubei Key Laboratory of Genetic Regulation and Integrative Biology, School…. Hauptthemen laut MEDLINE: Ubiquitin-Conjugating Enzymes, Thiazoles, Enzyme Inhibitors. Die Arbeit nennt 25 Literaturangaben. Gefördert von: Natural Science Foundation of Hubei Province, Central China Normal University, National Natural Science Foundation of China.
Abstract (Originalsprache)
UBE2 family of E2 ubiquitin-conjugating enzymes occupy central positions in multiple ubiquitination pathways and have been implicated in cancers, motivating efforts to develop chemical probes to interrogate their functions. In this study, we identified XY54 as a covalent modifier of UBE2D2 that engages both C85 and C111 by using an electrophile-first screening approach coupled with X-ray crystallography. Structure-guided structure−activity relationship optimization of XY54 yielded XY54-24, in which modifications of the amide and ester groups of XY54 selectively abolished its binding to C111 while enhancing affinity for C85. XY54-24 inhibited UBE2D2 enzymatic activity in vitro and suppressed the proliferation of A549 lung cancer cells. Collectively, this study identifies covalent aminothiazole scaffold inhibitors for targeting UBE2D2 and provides a structural foundation for further development of selective UBE2D2 chemical probes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Pesticide and Chemical Biology of Ministry of Education, Hubei Key Laboratory of Genetic Regulation and Integrative Biology, School of Life Sciences, Central China Normal University, Wuhan430079, China.
- State Key Laboratory of Bioactive Molecules and Druggability Assessment, College of Pharmacy, Jinan University, Guangzhou510632, China.
- Cancer Institute, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai200032, China.
- State Key Laboratory of Green Pesticide, College of Chemistry, Central China Normal University, Wuhan430079, China.
ORCID-Profile: Shuaishuai Ni, Yunyuan Huang, Xin Chen, Jinrong Min
Förderung
- Natural Science Foundation of Hubei Province
- Central China Normal University
- National Natural Science Foundation of China
- Natural Science Foundation of Wuhan
- Guangzhou Municipal Science and Technology Project
Zitieren
APA
Liu, S., Zheng, T., Wu, X., Wang, H., Ni, S., Dou, Y., Li, B., Wang, L., Huang, Y., Chen, X., & Min, J. (2026). Electrophile-First Screening Identifies Covalent Aminothiazole Scaffold Inhibitors for Ubiquitin-Conjugating Enzyme UBE2D2. Journal of Medicinal Chemistry, 69(21), 25914-25929. https://doi.org/10.1021/acs.jmedchem.6c01896
Vancouver
Liu S, Zheng T, Wu X, Wang H, Ni S, Dou Y, et al. Electrophile-First Screening Identifies Covalent Aminothiazole Scaffold Inhibitors for Ubiquitin-Conjugating Enzyme UBE2D2. Journal of Medicinal Chemistry. 2026;69(21):25914-25929. doi:10.1021/acs.jmedchem.6c01896
BibTeX
@article{Liu2026,
author = {Liu, Siying and Zheng, Tao and Wu, Xinyu and Wang, Huiling and Ni, Shuaishuai and Dou, Yilin and Li, Boyi and Wang, Lu and Huang, Yunyuan and Chen, Xin and Min, Jinrong},
title = {Electrophile-First Screening Identifies Covalent Aminothiazole Scaffold Inhibitors for Ubiquitin-Conjugating Enzyme UBE2D2},
journal = {Journal of Medicinal Chemistry},
year = {2026},
volume = {69},
number = {21},
pages = {25914--25929},
doi = {10.1021/acs.jmedchem.6c01896}
}
EUVIMED